Siemens Healthineers announced today that it intends to close its Fast Track Diagnostics Unit in a move that affects just shy of 100 workers. The business closure affects about 90 employees, mostly based in Luxembourg. The company has conversations underway with local employee representatives and plans to follow local labor regulations and guidelines in accordance […]
Genomics/Molecular Diagnostics
A high-ranking BD executive is set to retire
BD announced today that its EVP and President of Life Sciences, Dave Hickey, intends to retire this year. Hickey plans for his retirement to go into effect on July 1, 2024. He originally joined BD in 2014, serving as president of Diagnostic Systems. He took over as president of Integrated Diagnostic Solutions in 2019 and […]
FDA clears new cervical cytology AI tech from Hologic
Hologic announced that the FDA granted clearance for its Genius digital diagnostics system with the Genius cervical AI algorithm. Clearance makes Genius the first and only FDA-cleared digital cytology system combining deep learning-based AI with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells, according to a news release. Hologic’s clearance […]
The top IVD and diabetes tech stories of 2023
Over the course of 2023, the medtech industry produced another impressive year of innovation, with news coming from a variety of spaces. Chiefly among those were diabetes technologies and in vitro diagnostics (IVDs). We saw regulatory nods, product launches, funds raised and mergers fall apart. Looking at those two spaces in particular, here are five […]
Illumina will divest Grail after court backs FTC ruling
Illumina (Nasdaq:ILMN) announced that it plans to divest Grail after a drawn-out legal battle over the $7.1 billion acquisition. In September 2020, Illumina announced an agreement to acquire Grail, a DNA sequencing and array-based tech developer. Grail itself was a startup that initially spun out from the company in 2016. Illumina completed the acquisition in […]
Cytovale raises $84M Series C for sepsis diagnostic
Cytovale announced today that it raised $84 million in a Series C funding round to support its rapid sepsis diagnosis test. San Francisco-based Cytovale plans to use the funds to further expand the reach of its FDA-cleared IntelliSep sepsis test. The FDA cleared IntelliSep, which aids hospital emergency departments and health systems, in January. IntelliSep […]
Day Zero Diagnostics inks new partnership for bloodstream infection diagnostics
Day Zero Diagnostics and Oxford Nanopore today announced a collaboration to develop a solution for diagnosing bloodstream infections. Boston-based Day Zero Diagnostics develops diagnostics utilizing whole-genome sequencing and AI to combat antibiotic-resistant infections. Oxford Nanopore offers a new generation of nanopore-based molecular sensing technology. They seek to enable early detection to combat bloodstream infections as […]
Siemens Healthineers Diagnostics to lay off 300 workers in New Jersey
Siemens Healthineers Diagnostics filed with the state of New Jersey to confirm the planned layoffs of 300 employees at its Morris, New Jersey location. The latest round of layoffs for the company follows the elimination of 67 roles at a diagnostics facility in Flanders, New Jersey, in June. A number of companies around medtech enacted […]
Boston Scientific executive is Day Zero Diagnostics’ new board chair
Day Zero Diagnostics — which seeks to harness whole-genome sequencing and AI in the fight against antibiotic-resistant infections — has a Boston Scientific executive as its new board chair. Jeff Mirviss is presently EVP and president of the Peripheral Interventions Division at Boston Scientific. He was already an independent director on Boston-based Day Zero Diagnostics’ […]
EU orders Illumina to divest Grail after ‘unlawful’ merger
The European Commission today announced it has ordered Illumina (Nasdaq: ILMN) — the DNA sequencing and array-based tech developer — to unwind and divest its Grail acquisition. The decision follows the commission’s decision to prohibit the transaction in September 2022 over concerns the merger would be anticompetitive and “stifle” innovation in the market. Despite the […]
Day Zero Diagnostics completes $16M funding round
Day Zero Diagnostics — which seeks to harness whole-genome sequencing and AI in the fight against antibiotic-resistant infections — announced today that it has successfully wrapped up a $16M financing round. The latest round raises the Boston-based company’s venture capital funding total to $49M, coupled with over $18M in non-dilutive funding. “This funding is a […]